Bor-Wen Wu
Impact in
- Virology top 5%
- HIV Research and Treatment
- Biotechnology top 5%
- Cancer Research and Treatments
Papers in
-
- Cancer Research and Treatments 9
-
- HIV/AIDS drug development and treatment 8
- Co-authors
- Siegfried Reich (7 shared papers)Krzysztof Appelt (8 shared papers)Vincent J. Kalish (4 shared papers)Stephen W. Kaldor (3 shared papers)John S. Bomalaski (9 shared papers)Amy K. Patick (1 shared paper)David D. Ho (1 shared paper)Hongmei Mo (1 shared paper)
- Journals
- Journal of Clinical Oncology (6 papers)Journal of Medicinal Chemistry (2 papers)Clinical Cancer Research (1 paper)Investigational New Drugs (1 paper)Antimicrobial Agents and Chemotherapy (1 paper)
- Partner nations
- United StatesUnited KingdomTaiwan
In The Last Decade
Bor-Wen Wu
19 papers receiving 581 citations
Peers
Comparison fields: 5 of 62
- Virology 177
- Biotechnology 161
- Infectious Diseases 202
- Cancer Research 98
- Hepatology 27
Countries citing papers authored by Bor-Wen Wu
This map shows the geographic impact of Bor-Wen Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bor-Wen Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bor-Wen Wu more than expected).
Fields of papers citing papers by Bor-Wen Wu
This network shows the impact of papers produced by Bor-Wen Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bor-Wen Wu. The network helps show where Bor-Wen Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Bor-Wen Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 179 | |
| 2 | 2012 | 122 | |
| 3 | 2017 | 93 | |
| 4 | 1996 | 38 | |
| 5 | 2021 | 32 | |
| 6 | 1996 | 27 | |
| 7 | 1989 | 24 | |
| 8 | 2010 | 21 | |
| 9 | 1995 | 21 | |
| 10 | 1995 | 12 | |
| 11 | 2011 | 10 | |
| 12 | 2018 | 7 | |
| 13 | 2012 | 3 | |
| 14 | 2012 | 2 | |
| 15 | 1994 | 2 | |
| 16 | 2017 | 2 | |
| 17 | 2018 | 1 | |
| 18 | 2010 | 1 | |
| 19 | 1996 | 1 | |
| 20 | 1996 | 0 |
About Bor-Wen Wu
Bor-Wen Wu is a scholar working on Biotechnology, Infectious Diseases, Molecular Biology, Neurology and Organic Chemistry, having authored 21 papers that have together received 598 indexed citations. Recurring topics across this work include Cancer Research and Treatments (9 papers), HIV/AIDS drug development and treatment (8 papers), Neuroblastoma Research and Treatments (6 papers), Chemical Synthesis and Analysis (4 papers), HIV Research and Treatment (3 papers), Virus-based gene therapy research (3 papers), Click Chemistry and Applications (2 papers) and Synthesis and Reactivity of Heterocycles (2 papers). The work is most often cited by research in Virology (177 citations), Biotechnology (161 citations), Infectious Diseases (202 citations), Cancer Research (98 citations) and Hepatology (27 citations). Bor-Wen Wu has collaborated with scholars based in United States, United Kingdom and Taiwan. Frequent co-authors include Siegfried Reich, Krzysztof Appelt, Vincent J. Kalish, Stephen W. Kaldor, John S. Bomalaski, Amy K. Patick, David D. Ho, Hongmei Mo, S. E. Webber and Martin Markowitz. Their work appears in journals such as Journal of Clinical Oncology, Journal of Medicinal Chemistry, Clinical Cancer Research, Investigational New Drugs and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.